Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 2003-2007

  Hirono, Y ^a,d   Fushida, S ^a   Yonemura, Y ^a   Yamamoto, H ^a   Watanabe, H ^b   Raz, A ^c  

^a KANAZAWA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Keiju Hospital   (Japan)

Author keywords

Autocrine motility factor receptor; Cell motility; Gastric cancer; Invasion; Metastasis

Indexed keywords

AUTOCRINE MOTILITY FACTOR; AUTOCRINE MOTILITY FACTOR RECEPTOR; CYTOKINE RECEPTOR; GLYCOPROTEIN; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL TIME; TUMOR CELL;

EID: 0030469819     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.667     Document Type: Article

References (38)

1. ADACHI Y, KAMAKURA T, MORI M, MAEHARA Y AND SUGIMACHI K. (1994). Role of lymph node dissection and splenectomy in node-positive gastric carcinoma. Surgery, 116, 873-841.
2. ARETXABALA X, KONISHI K, YONEMURA Y, UENO K, YAGI M, NOGUCHI M, MIWA K AND MIYAZAKI I. (1987). Node dissection in gastric cancer. Br. J. Surg., 74, 770-773.
3. BABA H, MAEHARA Y, TAKEUCHI H, INUTSUKA S, OKUYAMA T, ADACHI Y, AKAZAWA K AND SUGIMACHI K. (1995). Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery, 117, 165-169.
4. BONENKAMP JJ, SONGUN I, HERMANS J, SASAKO M, WELVAART K, PLUKKER JT, VAN ELK P, OBERTOP H, GOUMA DJ, TAAT CW AND VAN LANSCHOT J, MEYERS S, DE GRAAF PW, VON MEYENFELDT MF, TILANUS H AND VAN DE VELDE CHJ. (1995). Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet, 345, 745-748.
5. COX DR. (1972). Regression model and life tables. J R Stat Soc B, 34, 187-220.
6. FIDLER IJ. (1990). Critical factors in the biology of human cancer metastasis: Twenty-eight GHA Clowes Memorial Award Lecture. Cancer Res., 50, 6130-6138.
7. FUJIMURA T, YONEMURA Y, FUSHIDA S, URADE M, TAKEGAWA S, KAMATA T, SUGIYAMA K, HASEGAWA H, KATAYAMA K, MIWA K AND MIYAZAKI, I. (1990). Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer, 65, 65-71.
8. HALLISSEY MT, DUNN JA, WARD LC AND ALLUM WH. (1994). The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet, 343, 1309-1312.
9. HART IR, GOODE NT AND WILSON RE. (1989). Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta, 989, 65-84.
10. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1995). Japanese Classification of Gastric Carcinoma. First English edition. Kanehara & Co., Ltd.: Tokyo.
11. LIOTTA LA, MANDLER R, MURANO G, KATZ DA, GORDON RK, CHIANG PK AND SCHIFFMANN E. (1986). Tumor cell autocrine motility factor. Proc. Natl Acad. Sci. USA, 83, 3302-3306.
12. MAEHARA Y, OKUYAMA T, OSHIRO T, BABA H, ADACHI Y AND SUGIMACHI K. (1994). Analysis of 390 patients surviving 10 years or longer after curative resection for gastric cancer. Oncology, 51, 366-371.
13. MARUYAMA K, WATANABE H, SHIOZAKI H, YANO H, INOUE M, TAMURA S, GOFUKU J, YAKAYAMA T, RAZ A AND MONDEN M. (1995). Expression of autocrine motility factor in human esophageal factor receptor in human esophageal cell carcinoma. Int. J. Cancer, 64, 316-321.
14. MOORADIAN DL, MCCARTHY JB, KOMANDURI KV AND FURCHT LT. (1992). Effects of transforming growth factor-b1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J. Natl Cancer Inst., 84, 523-527.
15. NABI IR, WATANABE H AND RAZ A. (1990). Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res., 50, 409-414.
16. NABI IR, WATANABE H, SILLETI S AND RAZ A. (1991). Tumor cell autocrine motility factor receptor. In Cell Motility Factors. Goldberg IR (ed.) pp. 163-177. Birkhäuser Verlag: Basle, Switzerland.
17. NABI IR, WATANABE H AND RAZ A. (1992). Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev., 11, 5-20.
18. NAKAMORI S, WATANABE H, KAMEYAMA M, IMAOKA S, FURUKAWA H, ISHIKAWA O, SASAKI Y, KABUTO T AND RAZ A. (1994). Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer, 74, 1855-1862.
19. NAKAZATO H, KOIKE A, SAJI S, OGAWA N AND SAKAMOTO J. (1994). Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet, 343, 1122-1126.
20. NEKARDA H, SCHMITT M, ULM K, WENNINGER A, VOGELSANG H, BECKER K, RODER JD, FINK U AND SIEWERT JR. (1994). Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res., 54, 2900-2907.
21. NINOMIYA I, ENDO Y, YONEMURA Y, NOGUCHI M, FUSHIDA S, NAKAI M, TAKAMURA H, HARADA F, SUZUKI T, MIYAZAKI I AND SASAKI T. (1992). Specific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription. Br. J. Cancer, 66, 84-87.
22. NOMURA H, SATO H, SEIKI M, MAI M AND OKADA Y. (1995). Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res., 55, 3263-3266.
23. OTTO T, BIRCHMEIER W, SCHMIDT U, HINKE A, SCHIPPER J, RUBBEN H AND RAZ A. (1994). Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res., 54, 3120-3123.
24. SATO H, TAKINO T, OKADA Y, CAO J, SHINAGAWA A, YAMAMOTO E AND SEIKI M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature, 370, 61-65.
25. SATO Y AND RIFKIN DB. (1988). Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, DNA synthesis plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107, 1199-1205.
26. SEPPÄ H, GROTENDORST G, SEPPÄ S, SCHIFFMANN E AND MARTIN GR. (1982). Platelet-derived growth factor is chemotactic for fibroblasts. J. Cell Biol., 92, 584-588.
27. SILLETTI M AND RAZ A. (1993). Autocrine motility factor is a growth factor. Biochem. Biophys. Res. Commun., 194, 446-457.
28. SILLETTI S, WATANABE H, HOGAN V, NABI IR AND RAZ A. (1991). Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res., 51, 3507-11.
29. STRACKE ML, ENGEL JD, WILSON LW, RECHLER MM, LIOTTA LA AND SCHIFFMANN E. (1989). The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J. Biol. Chem., 264, 21544-21549.
30. STRACKE ML, KRUTZSCH HC, UNSWORTH EJ, ÅRESTAD A, CIOCE V, SCHIFFMANN E AND LIOTTA LA. (1992). Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem., 267, 2524-2529.
31. TURLEY EA, AUSTIN L, VANDELIGT K AND CLARY C. (1991). Hyaluronan and a cell-associated hyaluronun binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol., 112, 1041-1047.
32. WATANABE H, CARMI P, HOGAN V, RAZ T, SILLETTI S, NABI IR AND RAZ A. (1991a). Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem., 266, 13442-13448.
33. WATANABE H, NABI IR AND RAZ A. (1991b). The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res., 51, 2699-2705.
34. WATANABE H, KANBE K AND CHIGIRA M. (1994). Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma. Clin. Exp. Metastasis, 12, 155-163.
35. WEIDNER KM, ARAKAKI N, HARTMAN G, VANDEKERCKHOVE J, WEINGART T, RIEDER H, FONATSCH C, TSUBOUCHI H, HISHIDA T, DAIKUHARA Y AND BIRCHMEIER W. (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl Acad. Sci. USA, 88, 7001-7005.
36. YONEMURA Y, KATAYAMA K, KAMATA T, FUSHIDA S, SEGAWA M, OOYAMA S, MIWA K AND MIYAZAKI I. (1991a). Surgical treatment of advanced gastric cancer with metastasis in paraaortic lymph node. Int. Surg., 76, 222-225.
37. YONEMURA Y, OOYAMA S, MATUMOTO H, KAMATA T, KIMURA H, TAKEGAWA S, KOSAKA T, YAMAGUCHI A, MIWA K AND MIYAZAKI I. (1991b). Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach. Int. Surg., 76, 226-229.
38. YONEMURA Y, NOJIMA N, KAJI M, FUJIMURA T, ITOH T, NINOMIYA I, MIYAZAKI I, ENDOU Y AND SASAKI T. 91995). E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer, 76, 941-953.